Genetic Polymorphism in the 5'-Flanking Region of Human CYP1A2 Gene : Effect on the CYP1A2 Inducibility in Humans

スポンサーリンク

概要

• 論文の詳細を見る
• Japanese Biochemical Societyの論文
• 1999-04-01

著者

• Fujieda Masaki

  北海道大学 薬学研究院薬物代謝学

• Fujieda Masaki

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Fujieda Masaki

  北海道大学 薬研究 代謝分析学

• 中島 美紀

  金沢大学 大学院医学系研究科薬物代謝化学

• 中島 美紀

  金沢大学薬学部薬物代謝化学教室

• Nakajima Miki

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Yokoi T

  Department Of Medicine And Clinical Science Gunma University Graduate School Of Medicine

• Yokoi Tsuyoshi

  北海道大学 薬研究 代謝分析

• KAMATAKI Tetsuya

  Laboratory of Drug Metabolism, Graduate School of Pharmaceutical Sciences, Hokkaido University

• YOKOI Tsuyoshi

  Laboratory of Drug Metabolism, Hokkaido University Graduate School of Pharmaceutical Sciences

• FUNAYAMA Masato

  Department of Legal Medicine, Sapporo Medical University

• 中島 美紀

  金沢大学大学院医学系研究科:金沢大学大学院薬学部

• 中島 美紀

  金沢大学大学院医学系研究科

• Kamataki T

  Hokkaido Univ. Sapporo Jpn

• Kamataki Tetsuya

  Department Of Pharmacology School Of Medicine Keio University:department Of Analytical Biochemistry

• MIZUTANI Mayumi

  Laboratory of Drug Metabolism, Graduate School of Pharmaceutical Sciences, Hokkaido University

• KINOSHITA Moritishi

  Otsuka Assay Laboratories, Otsuka Pharmaceutical Co.

• Yokoi Tsuyoshi

  Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci

• Yokoi T

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Yokoi Tsuyoshi

  Fac.pharm. Sci. Hokkaido Univ.

• Funayama Masato

  Department Of Forensic Medicine Tohoku University School Of Medicine

• Funayama M

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Fujieda Masaki

  Lab. Of Drug Metabolism And Pharmacokinetics Showa Pharmaceutical Univ.

• Kamataki Tetsuya

  Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci

• Mizutani Mayumi

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Kinoshita Moritishi

  Otsuka Assay Laboratories Otsuka Pharmaceutical Co.

• Kamataki Tetsuya

  Laboratory of Drug Metabolism, Hokkaido University Graduate School of Pharmaceutical Sciences

関連論文

• ラット小腸におけるP450およびグルクロン酸転移酵素の触媒活性:反転腸管とミクロソームの比較
• 抗糖尿病薬トログリタゾンの新規キノンエポキシド代謝物の同定と細胞障害性
• ヒトCYP1ファミリーの細胞特異的な誘導機構について
• ヒト肝ミクロソームのアミトリプチリンN-脱メチル化酵素活性のアルブミンによる促進作用
• テガフールからの5-フルオロウラシル生成におけるヒト肝P450およびチミジンホスホリラーゼの関与
• ヒトP450/P450還元酵素共発現系の触媒活性に及ぼすチトクロムb_5の影響
• ヒト肝P450によるフェニトインからのジヒドロキシ体生成活性に対するカタラーゼの促進効果
• トログリタゾンの代謝と肝細胞障害性の検討
• ◇◇ミニレビュー◇◇(平成11年度 日本薬物動態学会年会シンポジウムより) ヒト組換えP450酵素と肝ミクロソームを用いた薬物代謝反応におけるP450の役割の研究
• 降圧薬の内服により Phenocopy 現象をきたした1例
• 日本人成人におけるチトクローム P450遺伝子多型解析に対する検討
• R- 及び S-メホバルビタールの N-脱メチル化におけるヒト CYP2B6 の関与
• MACROMOLECULAR BINDING OF CARCINOGENIC/MUTAGENIC N- HYDROXYARYLAMINES THROUGH O-ACETYLATION PATHWAY
• MECHANISM OF MUTATION AND METABOLIC ACTIVATION OF NITRO-, NITROSO-, HYDROXYLAMINO-COMPOUNDS IN NITRO-COMPOUNDS RESISTANT MUTANTS OF AMES TESTAR STRAIN (TA98NR, TA98/1,8-DNP_6)
• Phenotyping と Genotyping の臨床的意義
• Two Novel Single Nucleotide Polymorphisms (SNPs) of the FMO3 Gene in Japanese
• A Mutation in the Flavin-containing Monooxygenase 3 Gene and its Effects on Catalytic Activity for N-oxidation of Trimethylamine In Vitro
• モルヒネのグルクロン酸抱合阻害による薬物相互作用の予測
• Urinary Excretion of Phenytoin Metabolites, 5-(4'-hydroxyphenyl)-5-Phenylhydantoin and its O-glucuronide in Humans and Analysis of Genetic Polymorphisms of UDP-glucuronosyltransferases
• Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver
• Immunohistochemical analysis of CYP2A13 in various types of human lung cancers
• チトクロームP450の遺伝子多型:CYP1A1,1A2,1B1,2D6,2E1 (特集 チトクロームP450遺伝子多型)
• ヒトCYP1A2の遺伝子変異と発がんリスクとの関連
• Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes(Biopharmacy)
• Co-operative Regulation of the Transcription of Human Dihydrodiol Dehydrogenase(DD)4/Aldo-Keot Reductase(AKR)1C4 Gene by Hepatocyte Nuclear Factor(HNF)-4α/γand HNF-1α.
• Characterization of a Novel Variant (S145C/L311V) of 3α-Hydroxysteroid/Dihydrodiol Dehydrogenase in Human Liver.
• CHARACTERIZATION OF TRANSGENIC MICE CARRYING A HUMAN FETUS-SPECIFIC CYP3A7.
• 高度の死体損壊を伴った幼児遺棄死体の剖検例
• 乳幼児突然死症候群の肺サ-ファクタント所見〔英文〕
• ヒト肝におけるニコチンおよびコチニンの代謝
• Inhibiton by EGCG of benzo[a]pyrene-induced mutations in the lung of HITEC mice.
• CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
• SUPPRESSION OF PPAR ALPHA SIGNAL CAUSED BY POLYCYCLIC AROMATIC HYDROCARBONS.(GENERAL SESSION BY POSTER PRESENTATION)(MOLECULAR TOXICITY & TOXICOGENOMICS)
• 2B-08 Establishment of Genetically Engineered E.coli Highly Sensitive to Nitrosamines by Introducing Human CYP2E1
• Twenty One Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2A6 Gene in Japanese and Caucasians
• Activities of Cytochrome P450 Enzymes in Liver and Kidney Microsomes from Systemic Carnitine Deficiency Mice with a Gene Mutation of Carnitine / Organic Cation Transporter
• CYP3A5 Contributes Significantly to CYP3A-mediated Drug Oxidations in Liver Microsomes from Japanese Subjects
• In vivo Evaluation of Coumarin and Nicotine as Probe Drugs to Predict the Metabolic Capacity of CYP2A6 Due to Genetic Polymorphism in Thais
• Novel Nonsynonymous Polymorphisms of the CYP1A1 Gene in Japanese
• Toxicological roles of human and rodent CYP2As in the mutagenic activation of N-nitrosamines.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
• Novel Mutations of the CYP2A6 Gene in a Thai Population with Lowered Capacity of Coumarin 7-Hydroxylation
• Genetic Polymorphism in the 5'-Flanking Region of Human CYP1A2 Gene : Effect on the CYP1A2 Inducibility in Humans
• Two Novel Haplotypes of CYP2D6 Gene in a Japanese Population
• Eighteen Novel Polymorphisms of the CYP2A13 Gene in Japanesse
• Large-scale Production of Genetically Engineered CYP3A4 in E. coli: Application of a Jarfermenter
• Application of Genetically Engineered Bacteria Carrying Human Cytochrome P450 to Toxicological Studies
• Metabolic Activation of Dimethylnitrosamine(DMN) by Human CYP2E1 Expressed in O^6-Methylguanine-DNA Methyltransferase-Deficient Cells
• EXPRESSION OF RECOMBINANT HUMAN CYTOCHROME P450 (P450 OR CYP) 2A6 IN ESCHERICHIA COLI.
• "S2-3 STRATEGIC PROPOSALS TO AVOID TOXIC DRUG INTERACTIONS DURING NEW DRUG DEVELOPMENT : MOLECULAR TOXICOLOGY PROPOSALS (Strategy how we can learn drug-drug interaction during the development of a new drug)
• Stable expression of CYP3A4 and CYP3A7, adult and fetal-specific forms of cytochrome P450 in human liver, in CHL cells and its application to toxicological testing.
• Effects of NO-1886 (Ibrolipim), a Lipoprotein Lipase-Promoting Agent, on Gene Induction of Cytochrome P450s, Carboxylesterases, and Sulfotransferases in Primary Cultures of Human Hepatocytes
• 抗がん薬のファーマコジェネティクス
• 抗がん薬のファーマコジェネティクス
• ニコチン代謝とCYP2A6の遺伝子多型
• S5-2 抗癌薬の代謝・副作用と遺伝子多型 : 臨床適用にむけた基礎研究の現状(遺伝子診断の臨床適用の現状,医療薬学の扉は開かれた)
• 平成16年度日本薬物動態学会奨励賞を受賞して
• ニコチン代謝とCYP2A6
• ヒトCYP1B1の転写調節機構 : 発がんとエストロゲンのホメオスタシス
• 喫煙とCMP2A6の遺伝子多型 (6月第1土曜特集 ファーマコゲノミクスとテーラーメイド医療) -- (臨床への応用)
• 癌の遺伝子治療とチトクロムP450
• ヒトCYP1A2の遺伝子多型と人種差に関する研究
• Detection of Three Genetic Polymorphisms in the 5'-Flanking Region and Intron 1 of Human CYP1A2 in the Japanese Population
• Homologous Unequal Cross-Over within the Human CYP2A Gene Cluster as a Mechanism for the Deletion of the Entire CYP2A6 Gene Associated with the Poor Metabolizer Phenotype
• Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor
• Thiopurine Methyltransferase Genotype and Phenotype Status in Japanese Patients with Systemic Lupus Erythematosus(Biopharmacy)
• Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients
• Sulfite is Generated from PAPS by Activated Neutrophils
• Extremely high levels of C-reactive protein in patients with acute lupus serositis
• Association of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults
• In silico および in vitro 技術を用いたヒトUDP-グルクロン酸転移酵素(UGT)1A9熱安定性の解析
• Binding of Steroidogenic Factor-1 to the Regulatory Region Might Not Be Critical for Transcriptional Regulation of the Human CYP1B1 Gene
• Critical Enhancer Region to Which AhR/ARNT and Sp1 Bind in the Human CYP1B1 Gene
• Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17
• Role of cyclosporin A in remitting nephrotic syndrome in a Japanese patient infected with human immunodeficiency virus type 1
• Acute Myeloid Leukemia Accompanied by Multiple Thrombophlebitis
• Production of Inhibitory Polyclonal Antibodies against Cytochrome P450s
• Desieg and Synthesis of para-Fluorophenylalanine Amide Derivatives as Thrombin Receptor Antagonists
• Interaction Mode of the Phe-Phenyl Group of Thrombin Receptor-Tethered Ligand SFLLRNP in Receptor Activation
• The Role of Arginine in Thrombin Receptor Tethered-Ligand Peptide in Intramolecular Receptor Binding and Self-Activation
• Separation of microsomal cytochrome b_5 via phase separation in a mixed solution of Triton X-114 and charged dextran
• Selective Solubilization of Microsomal Electron-Transfer Proteins with Alkylglucoside
• 21WA-04-2 Regulation of NAD(P)H: quinone oxidoreductase_1 (NQO_1) Gene Expression in Guinea Pig.
• Evaluation of rebreathing potential on bedding for infant use
• Inhibitory Effects of Kampo Medicine on Human UGT2B7 Activity
• Platelet Aggregation Activity of Thrombin Receptor-Tethered Peptide Ligand Containing Free Thiol or Activated SH Group
• Design and Synthesis of para-Fluorophenylalanine Amide Derivatives Containing N-Terminal Thiol as Thrombin Receptor Antagonist
• Correlation between Serum IL-6 Levels and Death : Usefulness in Diagnosis of "Traumatic Shock"?
• Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient
• Regional differences in homicide patterns in five areas of Japan
• Induction of Human CYP1A2 and CYP3A4 in Primary Culture of Hepatocytes from Chimeric Mice with Humanized Liver
• 教育・研究・医療機関編(2) : 新しい展開を模索して
• Update on Prediction of Drug Metabolizing Enzyme- and Transporter-based Drug Interactions
• Sudden death of a young woman due to aortic dissection caused by Turner's syndrome
• 虐待後に急死した乳児の剖検死因が吐物吸引であった一例
• Evaluation of Human CYP1A2 and CYP3A4 mRNA Expression in Hepatocytes from Chimeric Mice with Humanized Liver
• Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies
• 薬物動態と microRNA
• Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathway
• Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models
• Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor

もっと見る 閉じる

スポンサーリンク